Nataliia Rodyna
Nataliia Rodyna has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Anton Gerilovych
Institute for Problems of Cryobiology and Cryomedicine of NAS of Ukraine
2 shared publications - Dmytro Karamyshev
POLTAVA STATE MEDICAL UNIVERSITY, POLTAVA, UKRAINE
2 shared publications - T. I. Kupriyanova2 shared publications
- V.V. Maiboroda
Державна установа «Київський обласний центр контролю та профілактики хвороб Міністерств охорони здоров'я України», Київ, Україна
2 shared publications - I. O. Gerilovych
National Scientific Center ‘Institute of Experimental and Clinical Veterinary Medicine’, Kharkiv, Ukraine
1 shared publication - Ihor Kuzin
Bogomolets National Medical University, Ministry of Health of Ukraine
1 shared publication
Latest Publications
- Open Access
- 30 April 2025
- Published by Publishing House of National Academy Agrarian Sciences of Ukraine in One Health Journal
- Vol. 3 (3) , 5-31
Approaches to epidemiologic surveillance, diagnosis and prevention of West Nile fever in the Kyiv region
West Nile virus was first identified in Uganda in 1937 and remains a significant global threat to public health today. This virus is able to adapt to different ecosystems and spread geographically, especially in temperate climate areas of Europe and North America. Currently, cases of West Nile fever are reported in the United States, southern Canada, Mexico, Central and South America and the Caribbean, as well as in Africa, the Middle East, southern Europe, India and Indonesia, etc. West Nile fever has become more relevant in Ukraine, including in the Kyiv region in the last 10 years. According to data from the State Institution "Public Health Center of the Ministry of Health of Ukraine", 99 cases of West Nile fever were registered in Ukraine in 2024, 43 of them among residents of the Kyiv region. The manifestations of the disease vary in severity from mild and asymptomatic forms to fever clinic symptoms and central nervous system damage. However, there is no specific treatment for West Nile fever. Timely detection of West Nile virus disease cases requires improved laboratory diagnostics, national standards, and the development of an appropriate system of surveillance for West Nile fever at the national level. The authors present in this manuscript the results of the analysis of other countries' experience, the presence of a surveillance system in Ukraine, approaches to the laboratory diagnosis of West Nile fever, vectors control of West Nile virus on the example of the Kyiv region.
- 30 April 2025
- Published by Publishing House of National Academy Agrarian Sciences of Ukraine in One Health Journal
- Vol. 3 (3) , 5-31
Open AccessApproaches to epidemiologic surveillance, diagnosis and prevention of West Nile fever in the Kyiv region
West Nile virus was first identified in Uganda in 1937 and remains a significant global threat to public health today. This virus is able to adapt to different ecosystems and spread geographically, especially in temperate climate areas of Europe and North America. Currently, cases of West Nile fever are reported in the United States, southern Canada, Mexico, Central and South America and the Caribbean, as well as in Africa, the Middle East, southern Europe, India and Indonesia, etc. West Nile fever has become more relevant in Ukraine, including in the Kyiv region in the last 10 years. According to data from the State Institution "Public Health Center of the Ministry of Health of Ukraine", 99 cases of West Nile fever were registered in Ukraine in 2024, 43 of them among residents of the Kyiv region. The manifestations of the disease vary in severity from mild and asymptomatic forms to fever clinic symptoms and central nervous system damage. However, there is no specific treatment for West Nile fever. Timely detection of West Nile virus disease cases requires improved laboratory diagnostics, national standards, and the development of an appropriate system of surveillance for West Nile fever at the national level. The authors present in this manuscript the results of the analysis of other countries' experience, the presence of a surveillance system in Ukraine, approaches to the laboratory diagnosis of West Nile fever, vectors control of West Nile virus on the example of the Kyiv region.
- Open Access
- 12 August 2024
- Published by V. N. Karazin Kharkiv National University in State Formation
- Vol. 1 (35) , 269-280
Global health security index as a guideline for crisis management in ensuring resilience of the public health system
The article substantiates the conceptual approaches, principles and integration aspects of ensuring the sustainability of the public health system based on the assessment of the vulnerabilities of the relevant system using the global health security index as a crisis management tool under conditions of uncertainty, risks and threats of dangerous events. The concept of "One Health" is used as an integrated approach to health security. It has been proven that the Global Health Security Index can be used as a reference for identifying threats and preparedness for epidemics and pandemics with the ultimate goal of reducing their consequences for health care systems and the economy, both nationally and globally. Emphasis was placed on the fact that the use of global research data, in particular the global health safety index (GHS), will contribute to the implementation of the main functions of the main expert institution in the field of public health - the "Public Health Center of the Ministry of Health of Ukraine", in particular, with regard to coordination with issues of International Medical and Sanitary Regulations, as well as ensuring the functioning of national medical information systems for recording and analyzing data on infectious and non-infectious diseases. It is recommended to apply in practice the functioning of the national public health system integrated approaches based on international experience and practices related to the preservation of public health, based on its determinants, as well as the prevention of occurrence and response to dangerous events that may lead to the spread of mass infectious diseases and non-infectious diseases, other negative consequences.
- 12 August 2024
- Published by V. N. Karazin Kharkiv National University in State Formation
- Vol. 1 (35) , 269-280
Open AccessGlobal health security index as a guideline for crisis management in ensuring resilience of the public health system
The article substantiates the conceptual approaches, principles and integration aspects of ensuring the sustainability of the public health system based on the assessment of the vulnerabilities of the relevant system using the global health security index as a crisis management tool under conditions of uncertainty, risks and threats of dangerous events. The concept of "One Health" is used as an integrated approach to health security. It has been proven that the Global Health Security Index can be used as a reference for identifying threats and preparedness for epidemics and pandemics with the ultimate goal of reducing their consequences for health care systems and the economy, both nationally and globally. Emphasis was placed on the fact that the use of global research data, in particular the global health safety index (GHS), will contribute to the implementation of the main functions of the main expert institution in the field of public health - the "Public Health Center of the Ministry of Health of Ukraine", in particular, with regard to coordination with issues of International Medical and Sanitary Regulations, as well as ensuring the functioning of national medical information systems for recording and analyzing data on infectious and non-infectious diseases. It is recommended to apply in practice the functioning of the national public health system integrated approaches based on international experience and practices related to the preservation of public health, based on its determinants, as well as the prevention of occurrence and response to dangerous events that may lead to the spread of mass infectious diseases and non-infectious diseases, other negative consequences.
- Open Access
- 1 July 2024
- Published by Publishing House of National Academy Agrarian Sciences of Ukraine in One Health Journal
- Vol. 2 (III) , 23-31
EPIDEMIOLOGICAL INVESTIGATION OF A FATAL CASE OF DIPHTHERIA IN A RESIDENT OF KYIV OBLAST
Ukraine still has diphtheria. This infection is developed with toxins secreted by pathogens of three Corynebacteria species, such as Corynebacterium diphtheria, Corynebacterium ulcerans, and Corynebacterium pseudotuberculosis. In January 2024, for the first time in recent decade, a fatal case of diphtheria in a resident of the Kyiv oblast was registered in Ukraine. The results of laboratory testing showed the toxigenic microorganism Corynebacterium ulcerans. The diagnosis was established based on the results of the pathological and anatomical autopsy and confirmed by laboratory testing during the examination of sectional samples. When a woman sought medical attention with certain clinical signs, medical care personal did not collect biological samples from the patient for testing on the causative agents of respiratory diseases of viral or bacterial origin, and the primary diagnosis did not contain information about the warnings of diphtheria. This indicates a low alertness of doctors regarding the possibility of the occurrence and spread of diphtheria. The anti-vaccination attitude of the population and migration processes under martial law contribute to a decrease in the level of immunization in the Kyiv oblast and pose a threat to diphtheria outbreaks.
- 1 July 2024
- Published by Publishing House of National Academy Agrarian Sciences of Ukraine in One Health Journal
- Vol. 2 (III) , 23-31
Open AccessEPIDEMIOLOGICAL INVESTIGATION OF A FATAL CASE OF DIPHTHERIA IN A RESIDENT OF KYIV OBLAST
Ukraine still has diphtheria. This infection is developed with toxins secreted by pathogens of three Corynebacteria species, such as Corynebacterium diphtheria, Corynebacterium ulcerans, and Corynebacterium pseudotuberculosis. In January 2024, for the first time in recent decade, a fatal case of diphtheria in a resident of the Kyiv oblast was registered in Ukraine. The results of laboratory testing showed the toxigenic microorganism Corynebacterium ulcerans. The diagnosis was established based on the results of the pathological and anatomical autopsy and confirmed by laboratory testing during the examination of sectional samples. When a woman sought medical attention with certain clinical signs, medical care personal did not collect biological samples from the patient for testing on the causative agents of respiratory diseases of viral or bacterial origin, and the primary diagnosis did not contain information about the warnings of diphtheria. This indicates a low alertness of doctors regarding the possibility of the occurrence and spread of diphtheria. The anti-vaccination attitude of the population and migration processes under martial law contribute to a decrease in the level of immunization in the Kyiv oblast and pose a threat to diphtheria outbreaks.
- Open Access
- 6 March 2024
- Published by Publishing House of National Academy Agrarian Sciences of Ukraine in One Health Journal
- Vol. 2 (I) , 32-44
APPLICATION OF THE NEXT GENERATION SEQUENCING IN BIOLOGY AND MEDICINE
Next-Generation Sequencing (NGS), also known as high-throughput sequencing, refers to a set of modern DNA sequencing technologies that have revolutionized the field of genomics. Advantages of NGS techniques involving high speed (parallel sequencing is faster than traditional methods, allowing researchers to obtain results more quickly), cost-effectiveness (ability to sequence multiple fragments simultaneously reduces the cost per base compared to traditional sequencing), and scalability (platforms can be scaled to accommodate varying levels of throughput depending on experimental needs). NGS has significantly accelerated genomics research, enabling breakthroughs in fields such as personalized medicine, cancer genomics, and evolutionary biology. However, challenges such as data analysis complexity, error rates, and cost still exist and are areas of ongoing research and improvement within the field of sequencing technologies. Paper contains the brief explanation of the current NGS platforms and their features. NGS biomedical application is described with the main advantages and abilities of the analysed tools. Секвенування нового покоління (NGS), також відоме як високопродуктивне секвенування, відноситься до низки сучасних технологій секвенування ДНК, які зробили революцію в галузі геноміки. Переваги методів NGS включають високу швидкість (паралельне секвенування є швидшим за традиційні методи, що дозволяє дослідникам швидше отримувати результати), економічність (можливість секвенувати кілька фрагментів одночасно зменшує вартість бази порівняно з традиційним секвенуванням) і масштабованість (платформи можна масштабувати, щоб відповідати різним рівням пропускної здатності залежно від експериментальних потреб). NGS суттєво прискорило геномні дослідження, зробивщи можливим прорив у таких галузях, як персоналізована медицина, геноміка раку та еволюційна біологія. Однак такі проблеми, як складність аналізу даних, рівень помилок і вартість, все ще існують і є областями постійних досліджень і вдосконалень у сфері технологій секвенування. Стаття містить коротке пояснення поточних платформ NGS та їх особливості. Описано біомедичне застосування NGS з основними перевагами та можливостями аналізованих інструментів.
- 6 March 2024
- Published by Publishing House of National Academy Agrarian Sciences of Ukraine in One Health Journal
- Vol. 2 (I) , 32-44
Open AccessAPPLICATION OF THE NEXT GENERATION SEQUENCING IN BIOLOGY AND MEDICINE
Next-Generation Sequencing (NGS), also known as high-throughput sequencing, refers to a set of modern DNA sequencing technologies that have revolutionized the field of genomics. Advantages of NGS techniques involving high speed (parallel sequencing is faster than traditional methods, allowing researchers to obtain results more quickly), cost-effectiveness (ability to sequence multiple fragments simultaneously reduces the cost per base compared to traditional sequencing), and scalability (platforms can be scaled to accommodate varying levels of throughput depending on experimental needs). NGS has significantly accelerated genomics research, enabling breakthroughs in fields such as personalized medicine, cancer genomics, and evolutionary biology. However, challenges such as data analysis complexity, error rates, and cost still exist and are areas of ongoing research and improvement within the field of sequencing technologies. Paper contains the brief explanation of the current NGS platforms and their features. NGS biomedical application is described with the main advantages and abilities of the analysed tools. Секвенування нового покоління (NGS), також відоме як високопродуктивне секвенування, відноситься до низки сучасних технологій секвенування ДНК, які зробили революцію в галузі геноміки. Переваги методів NGS включають високу швидкість (паралельне секвенування є швидшим за традиційні методи, що дозволяє дослідникам швидше отримувати результати), економічність (можливість секвенувати кілька фрагментів одночасно зменшує вартість бази порівняно з традиційним секвенуванням) і масштабованість (платформи можна масштабувати, щоб відповідати різним рівням пропускної здатності залежно від експериментальних потреб). NGS суттєво прискорило геномні дослідження, зробивщи можливим прорив у таких галузях, як персоналізована медицина, геноміка раку та еволюційна біологія. Однак такі проблеми, як складність аналізу даних, рівень помилок і вартість, все ще існують і є областями постійних досліджень і вдосконалень у сфері технологій секвенування. Стаття містить коротке пояснення поточних платформ NGS та їх особливості. Описано біомедичне застосування NGS з основними перевагами та можливостями аналізованих інструментів.